Global Azilsartan API Market Research Report 2025

Publication ID:

PB501255069

Publication Date:

February 5, 2025

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Azilsartan API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Azilsartan API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Azilsartan API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Azilsartan API include Hangzhou Longshine Bio-Tech, Jiangsu Zhongbang Pharmaceutical, Jiangxi Synergy Pharmaceutical, Zhuhai Rundu Pharmaceutical, Lunan Pharmaceutical, Zydus Takeda Healthcare, ChemWerth Inc, Metrochem API, Ami Lifesciences Private Limited, Piramal Pharma Solutions, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Azilsartan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azilsartan API.
The Azilsartan API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Azilsartan API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azilsartan API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hangzhou Longshine Bio-Tech
Jiangsu Zhongbang Pharmaceutical
Jiangxi Synergy Pharmaceutical
Zhuhai Rundu Pharmaceutical
Lunan Pharmaceutical
Zydus Takeda Healthcare
ChemWerth Inc
Metrochem API
Ami Lifesciences Private Limited
Piramal Pharma Solutions
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
Kyongbo Pharmaceutical
Takeda Pharmaceutical
by Type
0.98
0.99
Others
by Application
Medical Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azilsartan API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Azilsartan API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Azilsartan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Azilsartan API Market Overview
1.1 Product Definition
1.2 Azilsartan API by Type
1.2.1 Global Azilsartan API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Azilsartan API by Application
1.3.1 Global Azilsartan API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Azilsartan API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Azilsartan API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Azilsartan API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Azilsartan API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Azilsartan API Production Market Share by Manufacturers (2020-2025)
2.2 Global Azilsartan API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Azilsartan API, Industry Ranking, 2023 VS 2024
2.4 Global Azilsartan API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Azilsartan API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Azilsartan API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Azilsartan API, Product Offered and Application
2.8 Global Key Manufacturers of Azilsartan API, Date of Enter into This Industry
2.9 Azilsartan API Market Competitive Situation and Trends
2.9.1 Azilsartan API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Azilsartan API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Azilsartan API Production by Region
3.1 Global Azilsartan API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Azilsartan API Production Value by Region (2020-2031)
3.2.1 Global Azilsartan API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Azilsartan API by Region (2026-2031)
3.3 Global Azilsartan API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Azilsartan API Production Volume by Region (2020-2031)
3.4.1 Global Azilsartan API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Azilsartan API by Region (2026-2031)
3.5 Global Azilsartan API Market Price Analysis by Region (2020-2025)
3.6 Global Azilsartan API Production and Value, Year-over-Year Growth
3.6.1 North America Azilsartan API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Azilsartan API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Azilsartan API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Azilsartan API Production Value Estimates and Forecasts (2020-2031)
4 Azilsartan API Consumption by Region
4.1 Global Azilsartan API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Azilsartan API Consumption by Region (2020-2031)
4.2.1 Global Azilsartan API Consumption by Region (2020-2025)
4.2.2 Global Azilsartan API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Azilsartan API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Azilsartan API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Azilsartan API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Azilsartan API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Azilsartan API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Azilsartan API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Azilsartan API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Azilsartan API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Azilsartan API Production by Type (2020-2031)
5.1.1 Global Azilsartan API Production by Type (2020-2025)
5.1.2 Global Azilsartan API Production by Type (2026-2031)
5.1.3 Global Azilsartan API Production Market Share by Type (2020-2031)
5.2 Global Azilsartan API Production Value by Type (2020-2031)
5.2.1 Global Azilsartan API Production Value by Type (2020-2025)
5.2.2 Global Azilsartan API Production Value by Type (2026-2031)
5.2.3 Global Azilsartan API Production Value Market Share by Type (2020-2031)
5.3 Global Azilsartan API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Azilsartan API Production by Application (2020-2031)
6.1.1 Global Azilsartan API Production by Application (2020-2025)
6.1.2 Global Azilsartan API Production by Application (2026-2031)
6.1.3 Global Azilsartan API Production Market Share by Application (2020-2031)
6.2 Global Azilsartan API Production Value by Application (2020-2031)
6.2.1 Global Azilsartan API Production Value by Application (2020-2025)
6.2.2 Global Azilsartan API Production Value by Application (2026-2031)
6.2.3 Global Azilsartan API Production Value Market Share by Application (2020-2031)
6.3 Global Azilsartan API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hangzhou Longshine Bio-Tech
7.1.1 Hangzhou Longshine Bio-Tech Azilsartan API Company Information
7.1.2 Hangzhou Longshine Bio-Tech Azilsartan API Product Portfolio
7.1.3 Hangzhou Longshine Bio-Tech Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.1.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.2 Jiangsu Zhongbang Pharmaceutical
7.2.1 Jiangsu Zhongbang Pharmaceutical Azilsartan API Company Information
7.2.2 Jiangsu Zhongbang Pharmaceutical Azilsartan API Product Portfolio
7.2.3 Jiangsu Zhongbang Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Jiangsu Zhongbang Pharmaceutical Main Business and Markets Served
7.2.5 Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates
7.3 Jiangxi Synergy Pharmaceutical
7.3.1 Jiangxi Synergy Pharmaceutical Azilsartan API Company Information
7.3.2 Jiangxi Synergy Pharmaceutical Azilsartan API Product Portfolio
7.3.3 Jiangxi Synergy Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Jiangxi Synergy Pharmaceutical Main Business and Markets Served
7.3.5 Jiangxi Synergy Pharmaceutical Recent Developments/Updates
7.4 Zhuhai Rundu Pharmaceutical
7.4.1 Zhuhai Rundu Pharmaceutical Azilsartan API Company Information
7.4.2 Zhuhai Rundu Pharmaceutical Azilsartan API Product Portfolio
7.4.3 Zhuhai Rundu Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Zhuhai Rundu Pharmaceutical Main Business and Markets Served
7.4.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
7.5 Lunan Pharmaceutical
7.5.1 Lunan Pharmaceutical Azilsartan API Company Information
7.5.2 Lunan Pharmaceutical Azilsartan API Product Portfolio
7.5.3 Lunan Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Lunan Pharmaceutical Main Business and Markets Served
7.5.5 Lunan Pharmaceutical Recent Developments/Updates
7.6 Zydus Takeda Healthcare
7.6.1 Zydus Takeda Healthcare Azilsartan API Company Information
7.6.2 Zydus Takeda Healthcare Azilsartan API Product Portfolio
7.6.3 Zydus Takeda Healthcare Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Zydus Takeda Healthcare Main Business and Markets Served
7.6.5 Zydus Takeda Healthcare Recent Developments/Updates
7.7 ChemWerth Inc
7.7.1 ChemWerth Inc Azilsartan API Company Information
7.7.2 ChemWerth Inc Azilsartan API Product Portfolio
7.7.3 ChemWerth Inc Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ChemWerth Inc Main Business and Markets Served
7.7.5 ChemWerth Inc Recent Developments/Updates
7.8 Metrochem API
7.8.1 Metrochem API Azilsartan API Company Information
7.8.2 Metrochem API Azilsartan API Product Portfolio
7.8.3 Metrochem API Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Metrochem API Main Business and Markets Served
7.8.5 Metrochem API Recent Developments/Updates
7.9 Ami Lifesciences Private Limited
7.9.1 Ami Lifesciences Private Limited Azilsartan API Company Information
7.9.2 Ami Lifesciences Private Limited Azilsartan API Product Portfolio
7.9.3 Ami Lifesciences Private Limited Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Ami Lifesciences Private Limited Main Business and Markets Served
7.9.5 Ami Lifesciences Private Limited Recent Developments/Updates
7.10 Piramal Pharma Solutions
7.10.1 Piramal Pharma Solutions Azilsartan API Company Information
7.10.2 Piramal Pharma Solutions Azilsartan API Product Portfolio
7.10.3 Piramal Pharma Solutions Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Piramal Pharma Solutions Main Business and Markets Served
7.10.5 Piramal Pharma Solutions Recent Developments/Updates
7.11 Alembic Pharmaceuticals Limited
7.11.1 Alembic Pharmaceuticals Limited Azilsartan API Company Information
7.11.2 Alembic Pharmaceuticals Limited Azilsartan API Product Portfolio
7.11.3 Alembic Pharmaceuticals Limited Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Alembic Pharmaceuticals Limited Main Business and Markets Served
7.11.5 Alembic Pharmaceuticals Limited Recent Developments/Updates
7.12 Aurobindo Pharma Limited
7.12.1 Aurobindo Pharma Limited Azilsartan API Company Information
7.12.2 Aurobindo Pharma Limited Azilsartan API Product Portfolio
7.12.3 Aurobindo Pharma Limited Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Aurobindo Pharma Limited Main Business and Markets Served
7.12.5 Aurobindo Pharma Limited Recent Developments/Updates
7.13 Glenmark Pharmaceuticals
7.13.1 Glenmark Pharmaceuticals Azilsartan API Company Information
7.13.2 Glenmark Pharmaceuticals Azilsartan API Product Portfolio
7.13.3 Glenmark Pharmaceuticals Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.13.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.14 Kyongbo Pharmaceutical
7.14.1 Kyongbo Pharmaceutical Azilsartan API Company Information
7.14.2 Kyongbo Pharmaceutical Azilsartan API Product Portfolio
7.14.3 Kyongbo Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Kyongbo Pharmaceutical Main Business and Markets Served
7.14.5 Kyongbo Pharmaceutical Recent Developments/Updates
7.15 Takeda Pharmaceutical
7.15.1 Takeda Pharmaceutical Azilsartan API Company Information
7.15.2 Takeda Pharmaceutical Azilsartan API Product Portfolio
7.15.3 Takeda Pharmaceutical Azilsartan API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Takeda Pharmaceutical Main Business and Markets Served
7.15.5 Takeda Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Azilsartan API Industry Chain Analysis
8.2 Azilsartan API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Azilsartan API Production Mode & Process Analysis
8.4 Azilsartan API Sales and Marketing
8.4.1 Azilsartan API Sales Channels
8.4.2 Azilsartan API Distributors
8.5 Azilsartan API Customer Analysis
9 Azilsartan API Market Dynamics
9.1 Azilsartan API Industry Trends
9.2 Azilsartan API Market Drivers
9.3 Azilsartan API Market Challenges
9.4 Azilsartan API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Hangzhou Longshine Bio-Tech
Jiangsu Zhongbang Pharmaceutical
Jiangxi Synergy Pharmaceutical
Zhuhai Rundu Pharmaceutical
Lunan Pharmaceutical
Zydus Takeda Healthcare
ChemWerth Inc
Metrochem API
Ami Lifesciences Private Limited
Piramal Pharma Solutions
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
Kyongbo Pharmaceutical
Takeda Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂